Wellspring Capital Management has announced it has acquired AdvoServ.
Wellspring, headquartered in New York, is a middle-market PE firm that manages more than $3 billion of private equity capital....more
Atreca has announced it has secured $56 million in series A funding.
Atreca, based in Redwood City, California, is a privately held biotechnology company developing therapeutics drawn from human immune responses,...more
Pamplona, based in London and New York, is a PE firm established in 2005. Pamplona manages over $10 billion in assets across a number of funds for a variety of clients. Pamplona is currently managing its fourth private equity...more
Quad-C, headquartered in Charlottesville, Va., is a middle market PE firm focused on investing in business services, consumer, general industrial, healthcare, specialty distribution and transportation/logistics companies. It...more
MTS Health Investors has announced it has sold portfolio company DNA Diagnostics Center (DDC) to GHO Capital Partners for $110 million.
DDC, based in Fairfield, Ohio, provides DNA testing services in three main areas:...more
Intellia, based in Cambridge, Mass., is gene editing company focused on the development of curative medicines utilizing a developed biological tool known as the CRISPR/Cas9 system....more
WAVE Life Sciences, based in Boston, is a genetic medicine company focused on developing stereopure nucleic acid therapies for patients impacted by rare diseases....more
Metacrine, based in San Diego, Calif., is a biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies....more
Precision BioSciences is a Durham, N.C.-based genome editing company. Its ARCUS genome editing technology is designed to produce nucleases that can insert, remove and modify DNA in a complex genome....more
Spirox has announced it has secured $18.5 million in series B funding.
Spirox, based in Menlo Park, Calif., develops minimally invasive technologies to treat nasal obstruction....more
Livongo, with offices in Chicago and Mountain View, Calif., is a developer of chronic disease management tools, including a cloud-enabled glucose meter....more
OrthoSensor has announced it has raised $19 million in a private placement of series C preferred stock.
OrthoSensor, based in Dania Beach, FL, is a developer of intelligent orthopedic devices and data services....more
Vascular Dynamics, headquartered in Mountain View, Calif., provides minimally invasive solutions for the treatment of refractive or resistant hypertension....more
CardioDx, headquartered in Redwood City, Calif., is a molecular diagnostics company specializing in cardiovascular genomics.
Participants in this round of financing included Alberta Investment Management Corp. and the...more